p53 acetylation enhances Taxol-induced apoptosis in human cancer cells

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Apoptosis

• Publication date

  2012-11-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10495-012-0772-8PMID 23161364
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Spindle poisons and cell fate: a tale of two pathways.

  2011cited by this paper
• Spindle Poisons and Cell Fate : A Tale of Two Pathways

  2011cited by this paper
• Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7

  2011cited by this paper
• Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel In Vitro and In Vivo

  2011cited by this paper
• Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells.

  2010cited by this paper
• Destruction's our delight: Controlling apoptosis during mitotic arrest

  2010cited by this paper
• Increasing p53 protein sensitizes non-small cell lung cancer to paclitaxel and cisplatin in vitro.

  2010cited by this paper
• A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours

  2010cited by this paper
• Phosphorylation of Mcl‐1 by CDK1–cyclin B1 initiates its Cdc20‐dependent destruction during mitotic arrest

  2010cited by this paper
• Acetylation of the DNA Binding Domain Regulates Transcription-independent Apoptosis by p53*

  2009cited by this paper
• Modes of p53 regulation.

  2009cited by this paper
• Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2

  2009cited by this paper
• The critical role of the class III histone deacetylase SIRT1 in cancer.

  2009cited by this paper
• p53 Acetylation Is Crucial for Its Transcription-independent Proapoptotic Functions*

  2009cited by this paper
• Acetylation is indispensable for p53 activation.

  2008cited by this paper
• Modulation of p53 function by SET8-mediated methylation at lysine 382.

  2007cited by this paper
• Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group

  2007cited by this paper
• On the road to cancer: aneuploidy and the mitotic checkpoint

  2005cited by this paper
• Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival.

  2005cited by this paper
• Cell cycle G2/M arrest and activation of cyclin-dependent kinases associated with low-dose paclitaxel-induced sub-G1 apoptosis

  2004cited by this paper
• Dependence of Paclitaxel Sensitivity on a Functional Spindle Assembly Checkpoint

  2004cited by this paper
• MDM2–HDAC1‐mediated deacetylation of p53 is required for its degradation

  2002cited by this paper
• Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics

  2002cited by this paper
• hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

  2001cited by this paper
• C-Terminal Ubiquitination of p53 Contributes to Nuclear Export

  2001cited by this paper
• Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner

  2001cited by this paper
• Cisplatinum and taxol induce different patterns of p53 phosphorylation.

  2001cited by this paper
• Taxanes and other microtubule stabilizing agents.

  1999cited by this paper
• A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors.

  1999cited by this paper
• Molecular effects of paclitaxel: Myths and reality (a critical review)

  1999cited by this paper
• Requirement for p53 and p21 to sustain G2 arrest after DNA damage.

  1998cited by this paper
• Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

  1997cited by this paper
• p53-independent apoptosis induced by paclitaxel through an indirect mechanism.

  1997cited by this paper
• p53 activity and chemotherapy

  1996cited by this paper
• Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

  1996cited by this paper
• Taxol-Induced Mitotic Block Triggers Rapid Onset of a p53-Independent Apoptotic Pathway

  1995cited by this paper

• Side-stepping the guardian of the genome: current cancer therapeutics targeting mutant p53

  2025cites this paper
• Tubulin/HDAC dual-target inhibitors: Insights from design strategies, SARs, and therapeutic potential.

  2024cites this paper
• Hyperforin-mediated anticancer mechanisms in MDA-MB-231 cell line: insights into apoptotic mediator modulation and caspase activation

  2023cites this paper
• Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer

  2022cites this paper
• 2-Methoxydiol derivatives as new tubulin and HDAC dual-targeting inhibitors, displaying antitumor and antiangiogenic response.

  2022cites this paper
• Hybrid Histone Deacetylase Inhibitor: an Effective Strategy for Cancer Therapy.

  2022cites this paper
• Therapeutic strategies to overcome taxane resistance in cancer.

  2021cites this paper
• Exploring the Roles of HERC2 and the NEDD4L HECT E3 Ubiquitin Ligase Subfamily in p53 Signaling and the DNA Damage Response

  2021cites this paper
• Natural Phytochemicals Derived from Gymnosperms in the Prevention and Treatment of Cancers

  2021cites this paper
• Comparative Evaluation of Apoptosis Induction Using Needles, Bark, and Pollen Extracts and Essential Oils of Pinus eldarica in Lung Cancer Cells

  2021cites this paper
• Anticancer potential of myricetin bulk and nano forms in vitro in lymphocytes from myeloma patients

  2020cites this paper
• Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer

  2019cites this paper
• Current opinion and mechanistic interpretation of combination therapy for castration-resistant prostate cancer

  2019cites this paper
• Effect of docetaxel-loaded lipid microbubble in combination with ultrasound-triggered microbubble destruction on the growth of a gastric cancer cell line.

  2019cites this paper
• Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure–Activity Relations of New Inhibitors of HDAC and/or Tubulin Function

  2019cites this paper
• The Sirt1/P53 Axis in Diabetic Intervertebral Disc Degeneration Pathogenesis and Therapeutics

  2019cites this paper
• Surgical peritoneal stress creates a pro-metastatic niche promoting resistance to apoptosis via IL-8

  2018cites this paper
• Histone deacetylase inhibitor AR-42 inhibits breast cancer cell growth and demonstrates a synergistic effect in combination with 5-FU.

  2018cites this paper
• Comparative Proteomic Analysis of Lysine Acetylation in Fish CIK Cells Infected with Aquareovirus

  2017cites this paper
• Anticancer potential of Azurin interaction with lipid rafts: deciphering the Role of Caveolae

  2016cites this paper
• miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC).

  2016cites this paper
• HSP25 down-regulation enhanced p53 acetylation by dissociation of SIRT1 from p53 in doxorubicin-induced H9c2 cell apoptosis

  2016cites this paper
• p28-Mediated Activation of p53 in G2-M Phase of the Cell Cycle Enhances the Efficacy of DNA Damaging and Antimitotic Chemotherapy.

  2016cites this paper
• Anti-Tumor Effects of the Polysaccharide Isolated from Tarphochlamys Affinis in H22 Tumor-Bearing Mice

  2016cites this paper
• Epothilones Suppress Neointimal Thickening in the Rat Carotid Balloon-Injury Model by Inducing Vascular Smooth Muscle Cell Apoptosis through p53-Dependent Signaling Pathway

  2016cites this paper
• The world of protein acetylation.

  2016cites this paper
• Regaining Taxol Sensitivity in Chemoresistant Ovarian Cancer Cells

  2015cites this paper
• Ketosis may promote brain macroautophagy by activating Sirt1 and hypoxia-inducible factor-1.

  2015cites this paper
• Antitumor activity of tatariside F isolated from roots of Fagopyrum tataricum (L.) Gaertn against H22 hepatocellular carcinoma via up-regulation of p53.

  2015cites this paper
• NiO nanoparticles induce apoptosis through repressing SIRT1 in human bronchial epithelial cells.

  2015cites this paper
• REGAINING TAXOL SENSITIVITY IN CHEMORESISTANT OVARIAN CANCER CELLS

  2015cites this paper
• Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.

  2015cites this paper
• Comprehensive profiling of lysine acetylation suggests the widespread function is regulated by protein acetylation in the silkworm, Bombyx mori

  2015cites this paper
• Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia

  2014cites this paper
• Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signalling

  2014cites this paper
• Microtubules and Their Role in Cellular Stress in Cancer

  2014cites this paper
• Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids.

  2014cites this paper
• ArhGAP30 promotes p53 acetylation and function in colorectal cancer

  2014cites this paper
• Pathway Modulations and Epigenetic Alterations in Ovarian Tumorbiogenesis

  2014cites this paper
• The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.

  2014cites this paper
• Formononetin suppresses the proliferation of human non-small cell lung cancer through induction of cell cycle arrest and apoptosis.

  2014cites this paper
• The discovery of colchicine-SAHA hybrids as a new class of antitumor agents.

  2013cites this paper